Erik S Knudsen

31PUBLICATIONS
176CO-AUTHORS
Molecular targetsCancer cell biologyCancer geneticsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Jul 02, 2026
CDK2 Inhibition Exerts RB-Independent Antitumor Activity in CDK4/6 Inhibitor-Resistant HR+/HER2- Breast Cancer.

|Apr 27, 2026
The evolving landscape of CDK inhibitor use in breast cancer therapy and beyond.

|Apr 24, 2026
Cyclin E modulates vulnerability to CDC7 kinase inhibition.

|Apr 16, 2026
Increasing Use of Germline Genetic Testing in Pancreatic Ductal Adenocarcinoma and Relationship to Clinical Outcome: A Single-Institution Study.

|Apr 10, 2026
Targeting Distinct Cell Cycle Nodes Overcomes KRAS/RAS Inhibitor Resistance.

Vishnu Kumarasamy, Jianxin Wang, Edwin Yau

|Jan 27, 2026
Biomarkers of response to neoadjuvant palbociclib plus anastrozole in endocrine-resistant estrogen receptor-positive/HER2-negative breast cancer: a phase 2 trial.

Tim Kong, Alex Mabry, Maureen Highkin

Pageof 6

Frequent Collaborators

11 joint publications

Agnieszka K Witkiewicz

8 joint publications

Jianxin Wang

4 joint publications

Ethan V Abel

4 joint publications

Vishnu Kumarasamy